NCT00940836 is a Phase 3 clinical trial of Resfenol in Common Cold, sponsored by Hospital de Clinicas de Porto Alegre.

Who is sponsoring NCT00940836?

NCT00940836 is sponsored by Hospital de Clinicas de Porto Alegre.

What drugs are being tested in NCT00940836?

Interventions in NCT00940836: Resfenol, Placebo, Co interventional acetaminophen.

What condition does NCT00940836 study?

NCT00940836 studies Common Cold, Flu-like Syndrome.

Is NCT00940836 still recruiting?

NCT00940836 is currently status unknown. Last updated 15 July 2009.

Last reviewed 2009-07-15 · How we verify

NCT00940836

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Phase III Clinical Trial - Efficacy and Safety Assessment of a Compound Acetaminophen, Chlorpheniramine and Phenylephrine Combination in the Symptomatic Treatment of Common Cold and Flu-Like Syndrome in Adults

Status unknown Phase 3 Last updated 15 July 2009

What this trial tests

Phase 3 trial testing Resfenol in Common Cold in 146 participants. Status unknown.

Timeline

1 June 2009

Primary endpoint
1 November 2009

Quick facts

Lead sponsor	Hospital de Clinicas de Porto Alegre
Phase	Phase 3
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	146
Start date	1 June 2009
Primary completion	1 November 2009
Sites	1 location across Brazil

Drugs / interventions tested

Resfenol — full drug profile →
Placebo
Co interventional acetaminophen — full drug profile →

Conditions studied

Common Cold — all drugs for Common Cold →
Flu-like Syndrome — all drugs for Flu-like Syndrome →

Sponsor

Hospital de Clinicas de Porto Alegre

Who can join

Adults 18 to 60, any sex, with Common Cold or Flu-like Syndrome. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Symptom improval assessed by questionnaires concerning headache, muscle ache, rhinorrhea, nasal obstruction, sneezes, cough, sore or irritated throat, hoarseness and fever, rated by patient himself in a scale from 0 to 4, being 0-absence and 4-severe.
Time frame: Questionnaires were answered at baseline and 1st followup to the investigator and during treatment at every dose, 5 times a day, from day 1 to 3/4, through patient's diary.

Sponsor's own description

The aim of this study is to assess the efficacy and safety of an anti-cold preparation compounded by acetaminophen, chlorpheniramine and phenylephrine for the treatment of cold and flu symptoms in healthy individuals in a randomized, double-blind, placebo-controlled clinical trial.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Common Cold

Currently open trials in the same condition.

NCT06724185 — Effects of LP28 on Immunity Enhancement in the Elderly · NA · recruiting
NCT06531707 — Efficacy and Safety in the Combination of Ibuprofen / Loratadine Versus Ibuprofen Versus Loratadine · Phase 3 · recruiting
NCT06697886 — A Study of the Efficacy and Safety of Antiwei Granules in the Treatment of Common Cold · Phase 3 · recruiting

Other Hospital de Clinicas de Porto Alegre trials

Trials by the same sponsor.

NCT07469722 — POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure · Phase 2, PHASE3 · not yet recruiting
NCT07264179 — Tracheal Cuff Pressure and Postoperative Complications: A Prospective Observational Study. · not yet recruiting
NCT07052058 — Triple-Blind Randomized Clinical Trial of Tocilizumab vs Placebo: Potential Use of an IL-6 Antagonist as an Adjuvant to · Phase 2 · not yet recruiting
NCT06953128 — General Versus Regional Anesthesia in Peripheral Arterial Surgery · NA · not yet recruiting
NCT06934707 — Meal Frequency and Glycemic Control in Individuals With Type 1 Diabetes · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00940836 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital de Clinicas de Porto Alegre
Last refreshed: 15 July 2009

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00940836.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing